Clinical Results with Recombinant Human Interleukin-3

This publication has 53 references indexed in Scilit:

• Hematopoietic Growth Factors
  New England Journal of Medicine, 1989
• Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation
  Nature, 1989
• Production of macrophage‐, granulocyte‐, granulocyte‐macrophage‐ and multi‐colony‐stimulating factor by peripheral blood cells
  European Journal of Immunology, 1989
• Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines
  Blood, 1989
• Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells
  Blood, 1988
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.
  Journal of Clinical Investigation, 1988
• Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.
  Proceedings of the National Academy of Sciences, 1988
• The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5
  Blood, 1988
• Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor
  Blood, 1987
• Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3
  Cell, 1986